340B ESP Wants to Be Pharma’s Go-to on 340B Duplicate Discounts. Kalderos Says Not So Fast.

A Message from Publisher and CEO Ted Slafsky: We recently welcomed FQHC 340B Compliances Services to our growing list of sponsors. In today’s sponsored content article, FQHC 340B Lead Consultant Michael Gonzalez offers five great tips on how covered entities can

Read More »

Key House Committee Rejects HRSA Request for More Regulatory Authority


A Message from Publisher and CEO Ted Slafsky: Happy Tuesday from sunny Washington, D.C.! I encourage you to read Comprehensive Pharmacy Services’ (CPS) article about its new white paper on navigating the 340B program during the COVID-19

Read More »

HRSA Says its 340B Contract Pharmacy Guidance Is Not Legally Enforceable


A note from Publisher and CEO Ted Slafsky: Attention 340B covered entities! I am honored and excited to be speaking on a virtual panel July 15 hosted by 340B Report sponsor PSG on the latest 340B

Read More »

Eli Lilly Says It Doesn’t Have to Provide 340B-Priced Drugs to Contract Pharmacies

A note from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Click on the button

Read More »

Breaking News

BREAKING: New U.S. Senate Bipartisan Bill Would Preserve Hospitals’ 340B Eligibility During Pandemic

New U.S. Senate Bipartisan Bill Would Preserve Hospitals’ 340B Eligibility During Pandemic

New bipartisan legislation in the U.S. Senate would “would provide certainty to hospitals participating in the 340B drug discount program during the COVID-19 public health emergency,” its

Read More »

More Evidence That 340B Program Guidance Is Unenforceable

A note from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Click on the button

Read More »

Brace Yourselves: A Major 340B Hospital Court Ruling and CMS Proposed Rule Are Coming


A note from Publisher and CEO Ted Slafsky: Happy Tuesday! I hope all is well with everyone and you get to enjoy the upcoming holiday. Our sponsors are 340B’s industry leaders and we are proud to

Read More »

Hospitals Might Not Get 340B Discounts on Drugs Being Investigated as COVID-19 Treatments


A note from Publisher and CEO Ted Slafsky: Please join us in welcoming FQHC 340B to our growing list of 340B Report sponsors. We look forward to partnering with them and having our readers learn

Read More »

House Bipartisan Bills Address Worries About COVID-19 Drug Price Gouging


A Message from Publisher and CEO Ted Slafsky:  Not only has the COVID-19 pandemic taken an enormous toll on health care workers, it has also been a major hit to 340B covered entities’ finances. I encourage

Read More »

MedPAC Report Endnote Sheds Light on Hospital Losses Due to CMS 340B Drug Payment Cuts


Happy Juneteenth from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Benefits

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live